Topic Archives: Mauldin Economics

Robert Ross is peddling his Yield Shark newsletter from Mauldin Economics, and he’s doing it with an all-too-familiar “enroll in this income stream” kind of idea… in his case, he calls it the “Social Security Catastrophe Plan” and implies that it can “Boost Your Retirement by $185,040 Today.” Like most such offerings, there’s an undercurrent […]

New “wealth and wellness” letter from Chris Wood, who has worked on a bunch of investment letters for different publishers, and Dr. Michael Roizen, who is a well-known wellness “guru” and works at the Cleveland Clinic. Aims to provide both stock picks for healthcare-related investments, and health tips for readers.

Several readers have been asking what Tony Sagami’s “Superfood” pitch is all about — this ad started running on Friday, I believe, and it’s a pitch for the Yield Shark newsletter, edited by Sagami and published by Mauldin Economics. And it is blissfully brief in comparison to the many “presentations” we suffer through each day… […]

That’s a subtle headline, right? I already issued a bit of a “brain dump” for the Irregulars this week, on Wednesday instead of Friday, but I couldn’t resist taking a little look at this latest teaser pitch from Patrick Cox for his Transformational Technology Alert. Quite a few readers have been asking about it, and […]

Comments

  • Avatar

    Emails that went out Dated May 7. Both should be on the Akts Site. Akoustis Announces First Pre-Production Order for...

  • Avatar

    Hmmm, just ran across this page inadvertently after signing up for Patrick Cox's newsletter via Mauldin Economics in ear...

  • Avatar

    I'm a retired money manager. Regarding newsletter publishers; invest in any of their recommendations at great risk to yo...

  • Avatar

    Patrick Cox is now working with John Mauldin at Mauldin Economics. Take care....

  • Avatar

    As we wrote in our review yesterday of this month's YS issue, most of them I could not buy. (Since you mentioned the pi...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch